Orum Therapeutics
- Business Model
- B2B
- Website
- orumrx.com
- Total Funding
- $184.0M
- Last Round
- $100.0M Venture RoundDec 2025
- Rounds
- 2
About
Therapeutic company developing protein degrader-antibody conjugates for cancer treatment.
Summary
Orum Therapeutics is a Biotech company. It has raised $184.0M in total across 2 rounds, most recently a $100.0M Venture Round round in Dec 2025. Investors include IMM Investment, KB Investment and Woori Venture Partners.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company